Clinical trial
SGLT2 Inhibitor Registry in Singapore
NCT02578563 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SGLT2 Inhibitor Registry in Singapore
- Lead sponsor
- AstraZeneca
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 12, 2016
- Completion date
- December 31, 2018
- Enrollment
- 201 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.